GSE252944 AKT inhibition 3 v 9 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE252944_AKT inhibition_3_v_9_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE252944_AKT inhibition_3_v_9_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE252944_AKT inhibition_3_v_9_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE252944_AKT inhibition_3_v_9_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

valyl-tRNA synthetase 1

Gene

GOLGA2 pseudogene 7

Gene

multidrug resistance-related protein

Gene

PAXX non-homologous end joining factor

Gene

brain cytoplasmic RNA 1

Gene

colorectal cancer associated 1

Gene

STAG3 cohesin complex component like 4 (pseudogene)

Gene

uncharacterized LOC102723360

Gene

long intergenic non-protein coding RNA 1118

Gene

TMEM220 antisense RNA 1

  • Gene

    valyl-tRNA synthetase 1


  • Gene

    GOLGA2 pseudogene 7


  • Gene

    multidrug resistance-related protein


  • Gene

    PAXX non-homologous end joining factor


  • Gene

    brain cytoplasmic RNA 1


  • Gene

    colorectal cancer associated 1


  • Gene

    STAG3 cohesin complex component like 4 (pseudogene)


  • Gene

    uncharacterized LOC102723360


  • Gene

    long intergenic non-protein coding RNA 1118


  • Gene

    TMEM220 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.